OHDSI Home | Forums | Wiki | Github

FDA's new novel safety signal policy

(Vojtech Huser) #1

About 1 month ago, FDA published an interesting new policy here on evaluating a novel safety signal.

It has a lot of procedural steps but the tables are interesting.

Some examples are

and here

It will be interesting if (hydroxychloroquine and Azithromycin) will ever be a subject to NISS.